13 Best Healthcare Stocks to Buy Under $10

Page 10 of 12

3. Dyne Therapeutics, Inc. (NASDAQ:DYN)

Stock Price: $8.78 

Number of Hedge Fund Holders: 46

Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7, Luca Issi from RBC Capital maintained a Buy rating on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a price target of $25.00.

In other news, Dyne Therapeutics, Inc. (NASDAQ:DYN) announced on June 30 that it entered into a $275 million non-dilutive senior secured term loan facility with Hercules Capital. The company expects the transaction to bolster its balance sheet as it continues with DYNE-101 and DYNE-251 through critical clinical and regulatory milestones, for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), respectively.

John Cox, president and chief executive officer of Dyne, stated that the company is well-positioned to execute its plans to deliver functional improvement to the neuromuscular community, supported by “$100 million funded upfront and access to additional capital aligned with clinical, regulatory, and commercial progress.” Dyne Therapeutics, Inc. (NASDAQ:DYN) is also nearing a potential US launch in DMD in 2027.

Dyne Therapeutics, Inc. (NASDAQ:DYN) develops innovative life-transforming therapies for genetically driven muscle diseases. The company has a brand portfolio for muscle diseases, including facioscapulohumeral muscular dystrophy, myotonic dystrophy type 1, and Duchenne muscular dystrophy.

Page 10 of 12